197 related articles for article (PubMed ID: 27007068)
1. Evidence for a central mode of action for etoricoxib (COX-2 inhibitor) in patients with painful knee osteoarthritis.
Arendt-Nielsen L; Egsgaard LL; Petersen KK
Pain; 2016 Aug; 157(8):1634-1644. PubMed ID: 27007068
[TBL] [Abstract][Full Text] [Related]
2. Fourteen days of etoricoxib 60 mg improves pain, hyperalgesia and physical function in individuals with knee osteoarthritis: a randomized controlled trial.
Moss P; Benson HAE; Will R; Wright A
Osteoarthritis Cartilage; 2017 Nov; 25(11):1781-1791. PubMed ID: 28778815
[TBL] [Abstract][Full Text] [Related]
3. Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial.
Yoo MC; Yoo WH; Kang SB; Park YW; Kim SS; Moon KH; Song YW; Min BW; Cho YJ; Moon SH; Bin SI; Baek HJ; Shim SC; Lee SW; Yoo DH; Mehta A; Skuban A; Cukrow DM; Vandormael K; Yan L
Curr Med Res Opin; 2014 Dec; 30(12):2399-408. PubMed ID: 25133963
[TBL] [Abstract][Full Text] [Related]
4. Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.
Gottesdiener K; Schnitzer T; Fisher C; Bockow B; Markenson J; Ko A; DeTora L; Curtis S; Geissler L; Gertz BJ;
Rheumatology (Oxford); 2002 Sep; 41(9):1052-61. PubMed ID: 12209041
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
Bingham CO; Sebba AI; Rubin BR; Ruoff GE; Kremer J; Bird S; Smugar SS; Fitzgerald BJ; O'Brien K; Tershakovec AM
Rheumatology (Oxford); 2007 Mar; 46(3):496-507. PubMed ID: 16936327
[TBL] [Abstract][Full Text] [Related]
6. Early response to COX-2 inhibitors as a predictor of overall response in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib and placebo.
Bingham CO; Smugar SS; Wang H; Tershakovec AM
Rheumatology (Oxford); 2009 Sep; 48(9):1122-7. PubMed ID: 19589894
[TBL] [Abstract][Full Text] [Related]
7. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice.
Moore RA; Moore OA; Derry S; Peloso PM; Gammaitoni AR; Wang H
Ann Rheum Dis; 2010 Feb; 69(2):374-9. PubMed ID: 19364730
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: A randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial.
Leung AT; Malmstrom K; Gallacher AE; Sarembock B; Poor G; Beaulieu A; Castro R; Sanchez M; Detora LM; Ng J
Curr Med Res Opin; 2002; 18(2):49-58. PubMed ID: 12017209
[TBL] [Abstract][Full Text] [Related]
9. Intra-articular onabotulinumtoxinA in osteoarthritis knee pain: effect on human mechanistic pain biomarkers and clinical pain.
Arendt-Nielsen L; Jiang GL; DeGryse R; Turkel CC
Scand J Rheumatol; 2017 Jul; 46(4):303-316. PubMed ID: 27733091
[TBL] [Abstract][Full Text] [Related]
10. Etoricoxib improves osteoarthritis pain relief, joint function, and quality of life in the extreme elderly.
Huang WN; Tso TK
Bosn J Basic Med Sci; 2018 Feb; 18(1):87-94. PubMed ID: 28954205
[TBL] [Abstract][Full Text] [Related]
11. A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis.
Puopolo A; Boice JA; Fidelholtz JL; Littlejohn TW; Miranda P; Berrocal A; Ko A; Cichanowitz N; Reicin AS
Osteoarthritis Cartilage; 2007 Dec; 15(12):1348-56. PubMed ID: 17631392
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis.
Zacher J; Feldman D; Gerli R; Scott D; Hou SM; Uebelhart D; Rodger IW; Ozturk ZE;
Curr Med Res Opin; 2003; 19(8):725-36. PubMed ID: 14687444
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a single preoperative dose of etoricoxib for postoperative pain relief in therapeutic knee arthroscopy: a randomized trial.
Lierz P; Losch H; Felleiter P
Acta Orthop; 2012 Dec; 83(6):642-7. PubMed ID: 23140090
[TBL] [Abstract][Full Text] [Related]
14. Etoricoxib improves pain, function and quality of life: results of a real-world effectiveness trial.
Lin HY; Cheng TT; Wang JH; Lee CS; Chen MH; Lei V; Lac C; Gammaitoni AR; Smugar SS; Chen WJ
Int J Rheum Dis; 2010 May; 13(2):144-50. PubMed ID: 20536599
[TBL] [Abstract][Full Text] [Related]
15. No effect of the cyclooxygenase-2 inhibitor etoricoxib on pre-emptive and post-operative analgesia in visceral surgery: results of a randomized controlled trial.
Fleckenstein J; Kohls N; Evtouchenko E; Lehmeyer L; Kramer S; Lang PM; Siebeck M; Mussack T; Hatz R; Heindl B; Conzen P; Rehm M; Czerner S; Zwißler B; Irnich D
Eur J Pain; 2016 Feb; 20(2):186-95. PubMed ID: 25828692
[TBL] [Abstract][Full Text] [Related]
16. Responder analysis and correlation of outcome measures: pooled results from two identical studies comparing etoricoxib, celecoxib, and placebo in osteoarthritis.
Bingham CO; Bird SR; Smugar SS; Xu X; Tershakovec AM
Osteoarthritis Cartilage; 2008 Nov; 16(11):1289-93. PubMed ID: 18514551
[TBL] [Abstract][Full Text] [Related]
17. Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial.
DeLemos BP; Xiang J; Benson C; Gana TJ; Pascual ML; Rosanna R; Fleming B
Am J Ther; 2011 May; 18(3):216-26. PubMed ID: 20215961
[TBL] [Abstract][Full Text] [Related]
18. Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489].
Curtis SP; Bockow B; Fisher C; Olaleye J; Compton A; Ko AT; Reicin AS
BMC Musculoskelet Disord; 2005 Dec; 6():58. PubMed ID: 16321158
[TBL] [Abstract][Full Text] [Related]
19. Pain management after elective hallux valgus surgery: a prospective randomized double-blind study comparing etoricoxib and tramadol.
Brattwall M; Turan I; Jakobsson J
Anesth Analg; 2010 Aug; 111(2):544-9. PubMed ID: 20584877
[TBL] [Abstract][Full Text] [Related]
20. Etoricoxib provides analgesic efficacy to patients after knee or hip replacement surgery: a randomized, double-blind, placebo-controlled study.
Rasmussen GL; Malmstrom K; Bourne MH; Jove M; Rhondeau SM; Kotey P; Ang J; Aversano M; Reicin AS;
Anesth Analg; 2005 Oct; 101(4):1104-1111. PubMed ID: 16192529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
